The new diterpene isodojaponin D inhibited LPS-induced microglial activation through NF-kappaB and MAPK signaling pathways

Ji Youn Lim, Tae Joon Won, Bang Yeon Hwang, Hak Rim Kim, Kwang Woo Hwang, Dong Geun Sul, So Young Park

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Neuroinflammation with prolonged microglial activation leads to increased levels of pro-inflammatory mediators and subsequently contributes to neuronal dysfunction and neuronal loss. Therefore, pharmacological suppression of neuroinflammation would theoretically slow the progression of neurodegenerative disease. In this study, we investigated the anti-inflammatory effects and possible mechanisms of isodojaponin D (19-hydroxy-1α,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide), a new diterpene isolated from Isodon japonicus against lipopolysaccharide(LPS)-induced microglial activation in BV2 cells. Results from RT-PCR and Western blot showed that pretreatment with isodojaponin D (5 and 10μg/ml) prior to treatment with LPS (1μg/ml) significantly decreased LPS-induced production of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in a dose-dependent manner. In addition, LPS-induced pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, were also decreased by pretreatment with isodojaponin D. This effect was accompanied by a decrease in translocations of Nuclear Factor-KappaB (NF-κB) p50 and p65 from the cytoplasm to the nucleus and by a decrease in I kappaB (IκB) degradation. In addition, pretreatment with isodojaponin D significantly attenuated LPS-induced mitogen-activated protein kinase (MAPK) activation. Taken together, these results suggest that isodojaponin D suppressed LPS-induced microglial activation and production of pro-inflammatory mediators by inhibition of the NF-κB signaling pathway and phosphorylation of MAPKs. These results suggest that isodojaponin D could play a beneficial role in treatment of neurodegenerative disease.

Original languageEnglish
Pages (from-to)10-18
Number of pages9
JournalEuropean Journal of Pharmacology
Volume642
Issue number1-3
DOIs
Publication statusPublished - 2010 Sep 1

Fingerprint

NF-kappa B
Diterpenes
Mitogen-Activated Protein Kinases
Lipopolysaccharides
Neurodegenerative Diseases
Isodon
Nitric Oxide Synthase Type II
Cyclooxygenase 2
Interleukin-1
19-hydroxy-1alpha,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide
Interleukin-6
Cytoplasm
Anti-Inflammatory Agents
Western Blotting
Phosphorylation
Pharmacology
Cytokines
Polymerase Chain Reaction

Keywords

  • BV2 cells
  • COX-2
  • Cytokines
  • INOS
  • Isodojaponin D (19-hydroxy-1,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide)
  • Lipopolysaccharide
  • MAPKs
  • NF-κB

ASJC Scopus subject areas

  • Pharmacology

Cite this

The new diterpene isodojaponin D inhibited LPS-induced microglial activation through NF-kappaB and MAPK signaling pathways. / Lim, Ji Youn; Won, Tae Joon; Hwang, Bang Yeon; Kim, Hak Rim; Hwang, Kwang Woo; Sul, Dong Geun; Park, So Young.

In: European Journal of Pharmacology, Vol. 642, No. 1-3, 01.09.2010, p. 10-18.

Research output: Contribution to journalArticle

Lim, Ji Youn ; Won, Tae Joon ; Hwang, Bang Yeon ; Kim, Hak Rim ; Hwang, Kwang Woo ; Sul, Dong Geun ; Park, So Young. / The new diterpene isodojaponin D inhibited LPS-induced microglial activation through NF-kappaB and MAPK signaling pathways. In: European Journal of Pharmacology. 2010 ; Vol. 642, No. 1-3. pp. 10-18.
@article{bcacfb44569c49feb695e5342f6dcd49,
title = "The new diterpene isodojaponin D inhibited LPS-induced microglial activation through NF-kappaB and MAPK signaling pathways",
abstract = "Neuroinflammation with prolonged microglial activation leads to increased levels of pro-inflammatory mediators and subsequently contributes to neuronal dysfunction and neuronal loss. Therefore, pharmacological suppression of neuroinflammation would theoretically slow the progression of neurodegenerative disease. In this study, we investigated the anti-inflammatory effects and possible mechanisms of isodojaponin D (19-hydroxy-1α,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide), a new diterpene isolated from Isodon japonicus against lipopolysaccharide(LPS)-induced microglial activation in BV2 cells. Results from RT-PCR and Western blot showed that pretreatment with isodojaponin D (5 and 10μg/ml) prior to treatment with LPS (1μg/ml) significantly decreased LPS-induced production of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in a dose-dependent manner. In addition, LPS-induced pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, were also decreased by pretreatment with isodojaponin D. This effect was accompanied by a decrease in translocations of Nuclear Factor-KappaB (NF-κB) p50 and p65 from the cytoplasm to the nucleus and by a decrease in I kappaB (IκB) degradation. In addition, pretreatment with isodojaponin D significantly attenuated LPS-induced mitogen-activated protein kinase (MAPK) activation. Taken together, these results suggest that isodojaponin D suppressed LPS-induced microglial activation and production of pro-inflammatory mediators by inhibition of the NF-κB signaling pathway and phosphorylation of MAPKs. These results suggest that isodojaponin D could play a beneficial role in treatment of neurodegenerative disease.",
keywords = "BV2 cells, COX-2, Cytokines, INOS, Isodojaponin D (19-hydroxy-1,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide), Lipopolysaccharide, MAPKs, NF-κB",
author = "Lim, {Ji Youn} and Won, {Tae Joon} and Hwang, {Bang Yeon} and Kim, {Hak Rim} and Hwang, {Kwang Woo} and Sul, {Dong Geun} and Park, {So Young}",
year = "2010",
month = "9",
day = "1",
doi = "10.1016/j.ejphar.2010.05.047",
language = "English",
volume = "642",
pages = "10--18",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - The new diterpene isodojaponin D inhibited LPS-induced microglial activation through NF-kappaB and MAPK signaling pathways

AU - Lim, Ji Youn

AU - Won, Tae Joon

AU - Hwang, Bang Yeon

AU - Kim, Hak Rim

AU - Hwang, Kwang Woo

AU - Sul, Dong Geun

AU - Park, So Young

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Neuroinflammation with prolonged microglial activation leads to increased levels of pro-inflammatory mediators and subsequently contributes to neuronal dysfunction and neuronal loss. Therefore, pharmacological suppression of neuroinflammation would theoretically slow the progression of neurodegenerative disease. In this study, we investigated the anti-inflammatory effects and possible mechanisms of isodojaponin D (19-hydroxy-1α,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide), a new diterpene isolated from Isodon japonicus against lipopolysaccharide(LPS)-induced microglial activation in BV2 cells. Results from RT-PCR and Western blot showed that pretreatment with isodojaponin D (5 and 10μg/ml) prior to treatment with LPS (1μg/ml) significantly decreased LPS-induced production of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in a dose-dependent manner. In addition, LPS-induced pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, were also decreased by pretreatment with isodojaponin D. This effect was accompanied by a decrease in translocations of Nuclear Factor-KappaB (NF-κB) p50 and p65 from the cytoplasm to the nucleus and by a decrease in I kappaB (IκB) degradation. In addition, pretreatment with isodojaponin D significantly attenuated LPS-induced mitogen-activated protein kinase (MAPK) activation. Taken together, these results suggest that isodojaponin D suppressed LPS-induced microglial activation and production of pro-inflammatory mediators by inhibition of the NF-κB signaling pathway and phosphorylation of MAPKs. These results suggest that isodojaponin D could play a beneficial role in treatment of neurodegenerative disease.

AB - Neuroinflammation with prolonged microglial activation leads to increased levels of pro-inflammatory mediators and subsequently contributes to neuronal dysfunction and neuronal loss. Therefore, pharmacological suppression of neuroinflammation would theoretically slow the progression of neurodegenerative disease. In this study, we investigated the anti-inflammatory effects and possible mechanisms of isodojaponin D (19-hydroxy-1α,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide), a new diterpene isolated from Isodon japonicus against lipopolysaccharide(LPS)-induced microglial activation in BV2 cells. Results from RT-PCR and Western blot showed that pretreatment with isodojaponin D (5 and 10μg/ml) prior to treatment with LPS (1μg/ml) significantly decreased LPS-induced production of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in a dose-dependent manner. In addition, LPS-induced pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α, were also decreased by pretreatment with isodojaponin D. This effect was accompanied by a decrease in translocations of Nuclear Factor-KappaB (NF-κB) p50 and p65 from the cytoplasm to the nucleus and by a decrease in I kappaB (IκB) degradation. In addition, pretreatment with isodojaponin D significantly attenuated LPS-induced mitogen-activated protein kinase (MAPK) activation. Taken together, these results suggest that isodojaponin D suppressed LPS-induced microglial activation and production of pro-inflammatory mediators by inhibition of the NF-κB signaling pathway and phosphorylation of MAPKs. These results suggest that isodojaponin D could play a beneficial role in treatment of neurodegenerative disease.

KW - BV2 cells

KW - COX-2

KW - Cytokines

KW - INOS

KW - Isodojaponin D (19-hydroxy-1,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide)

KW - Lipopolysaccharide

KW - MAPKs

KW - NF-κB

UR - http://www.scopus.com/inward/record.url?scp=77954617272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954617272&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2010.05.047

DO - 10.1016/j.ejphar.2010.05.047

M3 - Article

VL - 642

SP - 10

EP - 18

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -